EP2367493B1 - Electrosurgical device having a temperature measurement device for determining a temperature and/or a temperature change at a neutral electrode - Google Patents

Electrosurgical device having a temperature measurement device for determining a temperature and/or a temperature change at a neutral electrode Download PDF

Info

Publication number
EP2367493B1
EP2367493B1 EP09743877.4A EP09743877A EP2367493B1 EP 2367493 B1 EP2367493 B1 EP 2367493B1 EP 09743877 A EP09743877 A EP 09743877A EP 2367493 B1 EP2367493 B1 EP 2367493B1
Authority
EP
European Patent Office
Prior art keywords
temperature
impedance
current
electrosurgical device
neutral electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP09743877.4A
Other languages
German (de)
French (fr)
Other versions
EP2367493A1 (en
Inventor
Peter Selig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erbe Elecktromedizin GmbH
Original Assignee
Erbe Elecktromedizin GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erbe Elecktromedizin GmbH filed Critical Erbe Elecktromedizin GmbH
Priority to PL09743877T priority Critical patent/PL2367493T3/en
Publication of EP2367493A1 publication Critical patent/EP2367493A1/en
Application granted granted Critical
Publication of EP2367493B1 publication Critical patent/EP2367493B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B18/1233Generators therefor with circuits for assuring patient safety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/16Indifferent or passive electrodes for grounding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00797Temperature measured by multiple temperature sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08Sensors provided with means for identification, e.g. barcodes or memory chips

Definitions

  • the invention relates to an electrosurgical device according to claim 1.
  • HF current high-frequency current
  • the active electrode In a monopolar application usually only one active electrode is provided, to which a high-frequency alternating voltage is applied.
  • the active electrode is located, for example, on an electrosurgical instrument for cutting and / or coagulating tissue.
  • a neutral electrode it is necessary to attach a neutral electrode to the patient's body, which closes the circuit via the tissue lying between the active electrode and the neutral electrode.
  • the shape of the active electrode depends on the particular application.
  • the surface of the active electrode, through which alternating current is conducted into the tissue, is relatively small, so that in the immediate vicinity of the active electrode, a high current density and consequently also a high heat development arise.
  • the AC voltage applied to the active electrode is dissipated via the neutral electrode. It is important to ensure that the neutral electrode over a large area rests against the body of the patient and opposes the high-frequency alternating current only a low contact resistance.
  • bipolar application two active electrodes are provided between which the tissue to be treated is received.
  • the current flow is closed by the tissue lying between the two active electrodes so that it is heated when an HF voltage is applied. A large part of the current flows between the two active electrodes.
  • the transition impedances between the two electrode sections are determined by means of a resonant circuit. It is assumed that the transition impedance between the individual sections is considerably lower in the case of a large area contact of the neutral electrode.
  • a resistor is coupled into the treatment stream, the heating of which can be monitored by means of a thermal sensor.
  • the resistance should be chosen so that it essentially reflects real impedance relationships between the neutral electrode and the active electrode.
  • a suitable choice of resistance is very difficult, since the impedance values in each application are dependent on the method used, the instrument, the positioning of the instrument and the neutral electrode, the organ to be treated, etc.
  • the impedance between the two halves of a split neutral electrode is measured as previously described. This provides a guideline for the applied area since the resistance is anti-proportional to it. Furthermore, the current is measured via the neutral electrode and, together with the contact resistance, a theoretical power loss is estimated, which drops at the electrodes. This power loss can be compared with empirically determined limit values in order to draw conclusions about the temperature present at the neutral electrode. However, these approaches are very error-prone and can not provide safe protection against patient injury. Different tissue types are not considered here.
  • the object is achieved by an electrosurgical device according to claim 1.
  • the neutral electrode according to the invention has a contact agent layer which has a temperature-specific impedance.
  • the electrical resistance of the contact agent layer thus changes depending on the present temperature.
  • a temperature-specific impedance in the context of this invention means the change of the impedance as a function of the temperature within a relevant temperature range.
  • the relevant temperature range is between 10 and 100 ° C. Perhaps an interval of 20 to 70 ° C, in particular 20 to 60 ° C from.
  • the contact agent layer will have such a material property that the impedance decreases with increasing temperature, in particular within the relevant interval. Local heating of the neutral electrode leads to a drop in the measured impedance.
  • the impedance measuring device can thus always detect the lowest impedance and thus the section of the contact medium layer with the highest temperature.
  • the impedance measuring device comprises a measuring current generator, which is designed to provide a measuring current at a first electrode section and at a second electrode section.
  • the neutral electrode is subdivided into at least a first electrode section and a second electrode section. The measurement of the impedance is ensured between these two electrode sections. It is conceivable to measure a plurality of impedances between a plurality of electrode sections. Thus, a better detail resolution of the temperature conditions is achieved at the neutral electrode.
  • the neutral electrode thus serves not only for the application of the HF current, but also for the determination of the impedances or impedance ratios within or on the contact agent layer.
  • the measuring current generator can be designed to provide the measuring current with an alternating voltage, in particular with an alternating voltage with a frequency ⁇ 300 kHz, in particular ⁇ 150 kHz, in particular ⁇ 100 kHz. With such low frequencies compared to those used in the treatment by means of the RF current, an effective measurement of the impedance can be made. It is conceivable to separate measuring currents and HF currents for treatment by corresponding filters from one another and to evaluate them separately.
  • the electrode sections are electrically isolated from one another on the contact middle layer. In order to generate different potentials at the individual electrode sections, it is necessary to form them in such a way that they are electrically insulated from one another.
  • the HF generator can be designed to provide an HF current with an AC voltage having a frequency ⁇ 300 kHz, in particular ⁇ 1000 kHz. Such frequencies are common in HF surgery and capable of performing advantageous coagulation and transection of tissue. These frequencies are significantly different from the frequencies used for the measurement currents. Frequency filters can be used to separate the measurement voltage from the RF voltage.
  • the contact means layer can have an electrical impedance with a high temperature dependence, in particular with a (relative) impedance change ⁇ 1% per degree Celsius, in particular ⁇ 2% per degree Celsius.
  • a (relative) impedance change ⁇ 1% per degree Celsius in particular ⁇ 2% per degree Celsius.
  • the relative impedance change in the relevant temperature range is greater than 1% per degree Celsius.
  • the contact agent layer may comprise or consist of hydrogel.
  • the contact agent layer is formed of hydrogel.
  • hydrogel When applying RF current, hydrogel is used to reduce the contact resistance between the electrodes and the skin. Hydrogel has a strong dependence on the temperature with respect to its impedance. Therefore, hydrogel is very well suited to carry out the temperature determination according to the invention.
  • the hydrogel has a dual function in this case. For one, it serves the better Application of the HF current and / or mechanical attachment of the neutral electrode to the patient, on the other hand, it forms part of a temperature sensor.
  • the temperature measuring device may include an impedance integrating device configured to integrate impedance changes over a predetermined period of time to make heat balance estimates.
  • an impedance integrating device configured to integrate impedance changes over a predetermined period of time to make heat balance estimates.
  • the predetermined time period may include a plurality of activation and deactivation phases of the RF generator.
  • both the heating during the activation phase - RF current is applied - as well as the cooling during the deactivation phase - no RF current is applied - are taken into account in the assessment of the temperature.
  • the electrosurgical device may comprise a recognition device for determining parameters, in particular at least one electrode surface of the neutral electrode and / or a temperature coefficient.
  • the impedance values measured at a neutral electrode depend on a variety of factors. This includes the area of the neutral electrode, in particular the area of the electrode sections, their position relative to one another, the tissue resistance, etc. It is possible to store parameters relevant to the calculation of the temperature device-specifically, in particular neutral-electrode-specific.
  • the recognition device can determine or read these parameters and process them in corresponding models or calculations.
  • the recognition device may include a database having a plurality of parameters and a plurality of neutral electrode types, wherein the recognition device is adapted to detect a connection of a particular type of neutral electrode and to read out the parameters from the database accordingly.
  • the determination of the connected neutral electrode can therefore be automatic (eg via an RFID tag, which is located at the neutral electrode). Numerous other methods for determining the neutral electrode types are conceivable. It would also be possible, the neutral electrode types before treatment manually enter or make a determination of the relevant parameters in a given test position.
  • the electrosurgical device may comprise an interrupting device which is designed to interrupt or limit the HF current when a predetermined impedance change or when exceeding a predetermined temperature at the neutral electrode is exceeded. It is also conceivable that the interruption device emits a warning signal when falling below a predetermined impedance value.
  • the electrosurgical device can have a contact agent layer with such a material property that its impedance decreases with increasing temperature. That is, a material having a negative temperature coefficient can be used. Thus, it is possible to detect along the large-area neutral electrode sections with very low resistance due to particularly high temperatures.
  • the temperature measuring device for determining the temperature and / or the temperature change can take into account the effective value of the HF current, in particular of the applied HF current. For example, it is possible to calculate a relation between impedance change and effective value (eg ⁇ R / I HF ) in order to determine a temperature change and / or a resistance, in particular a tissue resistance or a contact resistance between electrode and tissue. Among other things, the resistance can reveal how well a neutral electrode rests against the tissue.
  • the electrosurgical device comprises a current integrating device, which according to the invention is designed to sum up a value with respect to the HF current, in particular the RMS value, over time, in particular a predetermined period, and the sum for determining the temperature and / or the temperature change with an impedance change to relate to. It is simpler and less flawed if both the impedance change and the sum of the applied RF current are considered over a given time interval.
  • the individual values can be related (eg, ⁇ R / ⁇ I HF ) to capture system characteristics and determine temperature and / or temperature changes.
  • the method also makes use of the dependence of the impedance of the contact agent layer on the present temperature. Because of the immediate neighborhood between the contact agent layer and the applying part of the neutral electrode, as well as the neighborhood between the contact agent layer and the tissue, a quick heat exchange takes place. It can be considered that the tissue temperature of the tissue immediately below the neutral electrode is substantially equal to the temperature of the neutral electrode and the contact agent layer. This makes it possible to carry out a realistic estimation of the temperature balance at the neutral electrode. An inadmissibly high temperature increase due to the applied HF current can be detected and prevented.
  • Step a) may be performed multiple times during a plurality of activation and deactivation phases to determine a plurality of impedance values.
  • the temperature profile or the individual temperature changes at the neutral electrode can be better assessed. A realistic estimate of the present temperature can be made.
  • step b) the duration of the activation and / or deactivation phase and / or an effective value of the HF current can be taken into account.
  • Step b) may include integration over a plurality of impedance values over time.
  • the method may include detecting an impedance change during an activation and / or deactivation phase. For example, it is possible to use the quotient between cooling time and impedance change to draw conclusions about the present temperature. It can probably be assumed that the neutral electrode cools faster at a strong temperature gradient between the neutral electrode and the environment. The change in impedance relative to time can thus provide an important parameter for determining the temperature.
  • the change in impedance as a function of temperature can be approximated sufficiently accurately by a linear equation.
  • polynomial equations with a higher degree can be used for approximation.
  • the specific temperature coefficient can be determined in advance in corresponding test positions. It is also conceivable to determine a multiplicity of temperature coefficients for a polynomial equation with a higher degree.
  • the method may include outputting a warning signal and / or shutting off or shutting down the RF current if the measured impedance change exceeds a predetermined limit.
  • a warning message can be output, the HF current can be interrupted or limited in order to preclude any damage to the patient.
  • the Fig. 1 shows an electrosurgical device comprising an RF generator system 30, a monopolar instrument 20 and a neutral electrode 10.
  • the RF generator system 30 provides an RF current I HF which is applied by means of the monopolar instrument 20 and the neutral electrode 10 to a torso 1 becomes.
  • the Fig. 1 represents a schematic cross section through this torso 1.
  • the neutral electrode 10 is attached to the torso 1 over a large area.
  • the monopolar instrument 20 accommodates an active electrode which has a substantially smaller area than the neutral electrode 10. The current flows from the active electrode to the neutral electrode. In the immediate vicinity of the active electrode, the current density is so high that a targeted coagulation or separation of tissue 3 (see. Fig. 3 ) can be carried out.
  • Fig. 2 3 shows essential components of the HF generator system 30. These include a control device 36, a display device 32, an operating device 34 and a measuring device 37.
  • the user of the electrosurgical device can activate or deactivate the HF current I HF via the operating device 34. Furthermore, it is possible to set various modes of operation, such as one for cutting tissue and another for coagulating it.
  • the controller 36 controls the RF generator 31, which provides an RF current I HF according to the specifications.
  • the display 32 may be used to display set parameters, such as the current operating mode.
  • the display device 32 can display a temperature currently present at the neutral electrode 10 and issue warnings that protect the patient from undesired damage from the treatment. According to the invention, the temperature of the neutral electrode 10 is determined by the measuring device 37 using a secondary current source 38. Once the neutral electrode 10 has a temperature that could possibly lead to burns, the RF generator 31 is turned off and the display 32 issues corresponding warnings.
  • the neutral electrode 10 in one embodiment, comprises a first electrode section 11 and a second electrode section 11 '.
  • the electrode sections 11, 11 ' are arranged on a carrier material in such a way that they are electrically insulated from one another.
  • the neutral electrode 10 is located between the individual electrode sections 11, 11 ', an electrical insulator or hydrogel 13.
  • it is a self-adhesive neutral electrode 10 having a layer of electrically conductive hydrogel 13 and for application of the HF Current I HF is glued to a fabric 3.
  • the present invention takes advantage of the fact that the hydrogel 13 has a strong temperature coefficient of impedance.
  • commercially available neutral electrodes 10 were measured with commercial hydrogel 13 in the temperature range of 25 ° C to 40 ° C, a relative impedance change of 2 to 4% per degree Celsius. This effect can be used to determine the temperature increase at the neutral electrode 10.
  • various other parameters must be considered.
  • the environmental conditions have a strong influence on the measured impedance R (T).
  • the measuring device 37 comprises the secondary current source 38.
  • This device provides a measuring current I measuring which is applied to the electrode sections 11, 11 '.
  • voltage measuring device 39 can be a measurement voltage U detected measurement .
  • the measuring device 37 can measure an overall impedance. In a first model it is assumed that this total impedance, as in the Fig. 3 shown, composed of several resistors.
  • the measuring current I measurement of the first electrode section 11 passes through the hydrogel 13, at least partially enters the tissue 3, again passes through the hydrogel 13 and reaches the second electrode section 11 '.
  • the total impedance is thus composed at least of a gel resistance R Gel1 , a tissue resistance R tissue and a second gel resistance R Gel2 .
  • the measuring device 37 can determine the gel resistances R Gel1 , R Gel2 by means of the measuring current I Mess .
  • the tissue resistance R tissue can be determined by further measurements or set to a constant value which corresponds to approximate resistances commonly encountered in tissue.
  • the relationship between the impedance R (T) of the hydrogel 13 and its temperature T can be modeled sufficiently accurately with a first-order temperature coefficient ⁇ .
  • higher order temperature coefficients can be added.
  • R (T) is the measured impedance at the temperature T
  • R (T 0 ) is an impedance at an output temperature T 0
  • is the specific temperature coefficient.
  • the specific temperature coefficient ⁇ can be determined, for example, within a test setup.
  • the X-axis indicates the course of time t in seconds.
  • the Y-axis gives impedance values R 1 , R 2 , R 3 , R 4 of a measured impedance R (T) in ohms (lower Line) and a temperature T (t) (upper line) present at the neutral electrode 10 in degrees Celsius. While the temperature values T 1 , T 2 , T 3 , T 4 decrease in the Y direction, the impedance values R 1 , R 2 , R 3 , R 4 increase along the Y direction.
  • the diagram shows an example of the course of an HF treatment with a neutral electrode 10 according to the invention.
  • the first temperature value T 1 is established in the hydrogel 13.
  • the first temperature value T 1 essentially corresponds to the body surface temperature of approximately 32 ° C.
  • the measuring device 37 can detect the first impedance value R 1 .
  • the HF generator 31 is activated with a low power (shown schematically by the ramp in the diagram).
  • the activation phase lasts until time t 2 .
  • the measured impedance R (T) drops to the impedance value R 3 .
  • the measuring device 37 Since the measuring device 37, the output temperature T 1 , the output impedance R 1 and the impedance value R 3 at time t 2 is known, it can calculate the temperature change .DELTA.T by means of the above-mentioned formula. Based on this, the absolute temperature value T 3 can be determined.
  • the measured impedance R (T) increases.
  • the temperature change ⁇ T can be determined based on the impedance change ⁇ R, since R 2 is measurable and R 3 , T 3 are known.
  • the measuring device 37 can therefore calculate the temperature T 2 from the current temperature change ⁇ T.
  • the temperature of the neutral electrode T (t) rises again. Again, the temperature change ⁇ T can be calculated.
  • further parameters can be processed. For example, it is conceivable to take into account the temperature change ⁇ T during a time interval. Thus, a strong drop in temperature during a relatively short deactivation phase can be used as an indicator that a relatively high temperature T (t) is present at the neutral electrode 10, since there is probably a strong temperature gradient to the environment. Numerous other methods are conceivable which exploit the effect that a direct correlation between the Impedance change ⁇ R of the hydrogel 13 and its temperature change ⁇ T is present.

Description

Die Erfindung betrifft ein elektrochirurgisches Gerät gemäß Anspruch 1.The invention relates to an electrosurgical device according to claim 1.

In der Hochfrequenzchirurgie wird elektrische Energie dem zu behandelnden Gewebe zugeführt. Hierbei wird generell zwischen einer monopolaren und einer bipolaren Anwendung des Hochfrequenzstroms (HF-Stroms) unterschieden.In high-frequency surgery, electrical energy is supplied to the tissue to be treated. In this case, a distinction is generally made between a monopolar and a bipolar application of the high-frequency current (HF current).

Bei einer monopolaren Anwendung ist üblicherweise nur eine Aktivelektrode vorgesehen, an die eine hochfrequente Wechselspannung angelegt wird. Die Aktivelektrode befindet sich beispielsweise an einem elektrochirurgischen Instrument zum Schneiden und/oder Koagulieren von Gewebe. Ferner ist eine Anbringung einer Neutralelektrode am Körper des Patienten erforderlich, durch die der Stromkreis über das zwischen Aktivelektrode und Neutralelektrode liegende Gewebe geschlossen wird. Die Form der Aktivelektrode hängt von der jeweiligen Anwendung ab. Die Oberfläche der Aktivelektrode, über die Wechselstrom in das Gewebe geleitet wird, ist verhältnismäßig klein, so dass in der direkten Umgebung der Aktivelektrode eine hohe Stromdichte und demzufolge auch eine hohe Wärmeentwicklung entstehen.In a monopolar application usually only one active electrode is provided, to which a high-frequency alternating voltage is applied. The active electrode is located, for example, on an electrosurgical instrument for cutting and / or coagulating tissue. Furthermore, it is necessary to attach a neutral electrode to the patient's body, which closes the circuit via the tissue lying between the active electrode and the neutral electrode. The shape of the active electrode depends on the particular application. The surface of the active electrode, through which alternating current is conducted into the tissue, is relatively small, so that in the immediate vicinity of the active electrode, a high current density and consequently also a high heat development arise.

Die Stromdichte nimmt mit dem Abstand von der Aktivelektrode stark ab, sofern nicht durch erhebliche Unterschiede in der Gewebeleitfähigkeit auch an weiteren Körperstellen hohe Stromdichten auftreten. Die an die Aktivelektrode angelegten Wechselspannung werden über die Neutralelektrode abgeleitet. Es ist darauf zu achten, dass die Neutralelektrode großflächig an dem Körper des Patienten anliegt und dem hochfrequenten Wechselstrom nur einen geringen Übergangswiderstand entgegensetzt.The current density decreases strongly with the distance from the active electrode, unless high current densities occur at other parts of the body due to considerable differences in the fabric conductivity. The AC voltage applied to the active electrode is dissipated via the neutral electrode. It is important to ensure that the neutral electrode over a large area rests against the body of the patient and opposes the high-frequency alternating current only a low contact resistance.

Bei der bipolaren Anwendung sind zwei Aktivelektroden vorgesehen, zwischen denen das zu behandelnde Gewebe aufgenommen wird. Der Stromfluss wird über das zwischen den beiden Aktivelektroden liegende Gewebe geschlossen, so dass dieses bei einem Anlegen einer HF-Spannung erhitzt wird. Dabei fließt ein Großteil des Stroms zwischen den beiden Aktivelektroden.In bipolar application, two active electrodes are provided between which the tissue to be treated is received. The current flow is closed by the tissue lying between the two active electrodes so that it is heated when an HF voltage is applied. A large part of the current flows between the two active electrodes.

Es kommt vor, dass die Neutralelektrode nicht korrekt am Patienten angebracht wird oder sich während der Behandlung teilweise ablöst. In diesen Fällen ist der Stromfluss auf die noch anliegenden Teile der Neutralelektrode beschränkt, was zu einer deutlich höheren Impedanz an dieser und allgemein zu einer höheren Stromdichte innerhalb des benachbarten Gewebes führen kann. Wie der nachfolgende Bezug auf Dokumente aus dem Stand der Technik zeigt, sind Überwachungssysteme bekannt, mit denen eine Beurteilung der Anbringungsqualität der Neutralelektrode möglich ist.It happens that the neutral electrode is not properly attached to the patient or partially peels off during treatment. In these cases, the current flow is limited to the remaining parts of the neutral electrode, which can lead to a significantly higher impedance at this and generally to a higher current density within the adjacent tissue. As the following reference to prior art documents shows, monitoring systems are known which allow an assessment of the mounting quality of the neutral electrode.

Beispielsweise ist aus der DE 10 2004 025 613 B4 ein Verfahren zur Bestimmung der Übergangsimpedanz zwischen zwei Teilelektroden oder Elektrodenabschnitten einer geteilten Neutralelektrode in der Hochfrequenzchirurgie bekannt. Hierbei werden mittels eines Schwingkreises die Übergangsimpedanzen zwischen den beiden Elektrodenabschnitten bestimmt. Es wird unterstellt, dass bei einem großflächigen Anliegen der Neutralelektrode die Übergangsimpedanz zwischen den einzelnen Abschnitten wesentlich geringer ist.For example, is from the DE 10 2004 025 613 B4 A method for determining the junction impedance between two partial electrodes or electrode sections of a divided neutral electrode in high-frequency surgery is known. In this case, the transition impedances between the two electrode sections are determined by means of a resonant circuit. It is assumed that the transition impedance between the individual sections is considerably lower in the case of a large area contact of the neutral electrode.

In letzter Zeit wurden Behandlungsmethoden entwickelt, bei denen relativ hohe HF-Ströme über eine längere Zeitdauer appliziert werden. Das Risiko einer Verbrennung des Gewebes an der Neutralelektrode ist bei diesem Verfahren erhöht. Somit kann es also auch bei einer korrekt angelegten Neutralelektrode je nach Behandlungsverfahren oder Behandlungsverlauf zu einer Schädigung des Gewebes kommen. Theoretisch wäre es zwar denkbar, die Anlagefläche der Neutralelektrode weiter zu vergrößern, jedoch ist dies oft nicht praktikabel.Recently, treatment methods have been developed in which relatively high RF currents are applied over a longer period of time. The risk of tissue burning at the neutral electrode is increased in this process. Thus, even with a correctly applied neutral electrode, damage to the tissue may occur depending on the treatment method or course of treatment. Theoretically, it would be possible to further increase the contact surface of the neutral electrode, but this is often not practical.

Daher ist es notwendig, die Temperatur an der Neutralelektrode zu überwachen. Die US 2006/0079872 A1 stellt hierfür eine Vorrichtung bereit. Gemäß dieser Druckschrift wird ein Widerstand in den Behandlungsstrom eingekoppelt, dessen Erwärmung mittels eines Wärmesensors überwachbar ist. Der Widerstand soll so gewählt sein, dass er im Wesentlichen reale Impedanzverhältnisse zwischen der Neutralelektrode und der Aktivelektrode wiedergibt. Eine geeignete Wahl des Widerstands ist jedoch sehr schwierig, da sich die Impedanzwerte bei jeder Anwendung abhängig von der verwendeten Methode, dem Instrument, der Positionierung des Instruments und der Neutralelektrode, dem zu behandelnden Organ usw. ändern.Therefore, it is necessary to monitor the temperature at the neutral electrode. The US 2006/0079872 A1 provides a device for this purpose. According to this document, a resistor is coupled into the treatment stream, the heating of which can be monitored by means of a thermal sensor. The resistance should be chosen so that it essentially reflects real impedance relationships between the neutral electrode and the active electrode. However, a suitable choice of resistance is very difficult, since the impedance values in each application are dependent on the method used, the instrument, the positioning of the instrument and the neutral electrode, the organ to be treated, etc.

Es gibt weitere Ansätze, bei denen es angedacht ist, handelsübliche Temperatursensoren unmittelbar an den Elektroden vorzusehen. Das Bereitstellen dieser Messeinrichtungen an den Elektroden ist jedoch sehr aufwändig. Des Weiteren kommt es häufig zu lokalen Erwärmungen, die möglicherweise von diesen Sensoren nicht erfasst werden können.There are other approaches in which it is envisaged to provide commercial temperature sensors directly to the electrodes. The provision of these measuring devices to the electrodes is very complex. Furthermore, there are frequent localized warming events that may not be detected by these sensors.

In der Regel wird die Impedanz zwischen den beiden Hälften einer geteilten Neutralelektrode wie bereits beschrieben gemessen. Dies liefert einen Richtwert für die angelegte Fläche, da der Widerstand anti-proportional zu dieser ist. Des Weiteren wird der Strom über die Neutralelektrode gemessen und zusammen mit dem Übergangswiderstand wird eine theoretische Verlustleistung abgeschätzt, die an den Elektroden abfällt. Diese Verlustleistung lässt sich mit empirisch ermittelten Grenzwerten vergleichen, um Rückschlüsse auf die an der Neutralelektrode vorliegende Temperatur zu ziehen. Diese Ansätze sind jedoch sehr fehlerbehaftet und können keinen sicheren Schutz vor einer Schädigung des Patienten liefern. Unterschiedliche Gewebetypen werden hierbei nicht berücksichtigt.Typically, the impedance between the two halves of a split neutral electrode is measured as previously described. This provides a guideline for the applied area since the resistance is anti-proportional to it. Furthermore, the current is measured via the neutral electrode and, together with the contact resistance, a theoretical power loss is estimated, which drops at the electrodes. This power loss can be compared with empirically determined limit values in order to draw conclusions about the temperature present at the neutral electrode. However, these approaches are very error-prone and can not provide safe protection against patient injury. Different tissue types are not considered here.

Ausgehend von diesem Stand der Technik, insbesondere von der EP 1 707 151 A2 , ist es Aufgabe der vorliegenden Erfindung, ein elektrochirurgisches Gerät mit einer verbesserten Temperaturmesseinrichtung anzugeben. Des Weiteren soll ein entsprechendes Verfahren zur Bestimmung einer Temperatur und/oder Temperaturänderung an einer Neutralelektrode bereitgestellt werden. Insbesondere sollen das Verfahren und die Vorrichtung eine sichere und effiziente Beurteilung der Temperaturverhältnisse an der Neutralelektrode ermöglichen.Based on this prior art, in particular of the EP 1 707 151 A2 , It is an object of the present invention to provide an electrosurgical device with an improved temperature measuring device. Furthermore, a corresponding method is to be provided for determining a temperature and / or temperature change at a neutral electrode. In particular, the method and the device should enable a safe and efficient assessment of the temperature conditions at the neutral electrode.

Die Aufgabe wird erfindungsgemäß durch ein elektrochirurgisches Gerät gemäß dem Anspruch 1 gelöst.The object is achieved by an electrosurgical device according to claim 1.

Ein zentraler Gedanke besteht also darin, die Temperatur der Neutralelektrode oder deren Temperaturänderung anhand von Impedanzmessungen abzuschätzen. Hierfür weist die erfindungsgemäße Neutralelektrode eine Kontaktmittelschicht auf, die eine temperaturspezifische Impedanz hat. Der elektrische Widerstand der Kontaktmittelschicht ändert sich also in Abhängigkeit von der vorliegenden Temperatur. Unter einer temperaturspezifischen Impedanz im Sinne dieser Erfindung ist die Veränderung der Impedanz in Abhängigkeit von der Temperatur innerhalb eines relevanten Temperaturbereichs gemeint. Für die Elektrochirurgie liegt der relevante Temperaturbereich im Intervall zwischen 10 und 100°C. Möglicherweise reicht ein Intervall von 20 bis 70°C, insbesondere 20 bis 60°C aus.A central idea is therefore to estimate the temperature of the neutral electrode or its temperature change on the basis of impedance measurements. For this purpose, the neutral electrode according to the invention has a contact agent layer which has a temperature-specific impedance. The electrical resistance of the contact agent layer thus changes depending on the present temperature. A temperature-specific impedance in the context of this invention means the change of the impedance as a function of the temperature within a relevant temperature range. For electrosurgery the relevant temperature range is between 10 and 100 ° C. Perhaps an interval of 20 to 70 ° C, in particular 20 to 60 ° C from.

Vorzugsweise wird die Kontaktmittelschicht eine derartige Materialeigenschaft aufweisen, dass die Impedanz mit zunehmender Temperatur abnimmt, insbesondere innerhalb des relevanten Intervalls. Bei lokalen Erwärmungen der Neutralelektrode kommt es zu einem Abfall der gemessenen Impedanz. Die Impedanzmesseinrichtung kann also stets die geringste Impedanz und somit den Abschnitt der Kontaktmittelschicht mit der höchsten Temperatur erfassen.Preferably, the contact agent layer will have such a material property that the impedance decreases with increasing temperature, in particular within the relevant interval. Local heating of the neutral electrode leads to a drop in the measured impedance. The impedance measuring device can thus always detect the lowest impedance and thus the section of the contact medium layer with the highest temperature.

Die Impedanzmesseinrichtung umfaßt einen Messstromgenerator, der zur Bereitstellung eines Messstroms an einem ersten Elektrodenabschnitt und an einem zweiten Elektrodenabschnitt ausgebildet ist. Es wird also die Neutralelektrode in mindestens einen ersten Elektrodenabschnitt und einen zweiten Elektrodenabschnitt unterteilt. Die Messung der Impedanz wird zwischen diesen beiden Elektrodenabschnitten gewährleistet. Denkbar ist eine Messung einer Vielzahl von Impedanzen zwischen einer Vielzahl von Elektrodenabschnitten. Somit wird eine bessere Detailauflösung der Temperaturverhältnisse an der Neutralelektrode erzielt. Die Neutralelektrode dient also nicht nur zur Applikation des HF-Stroms, sondern auch zur Bestimmung der Impedanzen bzw. Impedanzverhältnisse innerhalb oder an der Kontaktmittelschicht.The impedance measuring device comprises a measuring current generator, which is designed to provide a measuring current at a first electrode section and at a second electrode section. Thus, the neutral electrode is subdivided into at least a first electrode section and a second electrode section. The measurement of the impedance is ensured between these two electrode sections. It is conceivable to measure a plurality of impedances between a plurality of electrode sections. Thus, a better detail resolution of the temperature conditions is achieved at the neutral electrode. The neutral electrode thus serves not only for the application of the HF current, but also for the determination of the impedances or impedance ratios within or on the contact agent layer.

Der Messstromgenerator kann zur Bereitstellung des Messstroms mit einer Wechselspannung, insbesondere mit einer Wechselspannung mit einer Frequenz ≤ 300 kHz, insbesondere ≤ 150 kHz, insbesondere ≤ 100 kHz ausgebildet sein. Mit derart niedrigen Frequenzen im Vergleich zu denen, die bei der Behandlung mittels des HF-Stroms verwendet werden, kann eine effektive Messung der Impedanz erfolgen. Denkbar ist es, Messströme und HF-Ströme für die Behandlung durch entsprechende Filter voneinander zu trennen und getrennt auszuwerten.The measuring current generator can be designed to provide the measuring current with an alternating voltage, in particular with an alternating voltage with a frequency ≦ 300 kHz, in particular ≦ 150 kHz, in particular ≦ 100 kHz. With such low frequencies compared to those used in the treatment by means of the RF current, an effective measurement of the impedance can be made. It is conceivable to separate measuring currents and HF currents for treatment by corresponding filters from one another and to evaluate them separately.

Die Elektrodenabschnitte sind elektrisch voneinander isoliert auf der Kontaktmittelschicht angeordnet. Um unterschiedliche Potentiale an den einzelnen Elektrodenabschnitten zu generieren, ist es notwendig, diese derart auszubilden, dass sie voneinander elektrisch isoliert sind.The electrode sections are electrically isolated from one another on the contact middle layer. In order to generate different potentials at the individual electrode sections, it is necessary to form them in such a way that they are electrically insulated from one another.

Der HF-Generator kann zur Bereitstellung eines HF-Stroms mit einer Wechselspannung mit einer Frequenz ≥ 300 kHz, insbesondere ≥ 1000 kHz ausgebildet sein. Derartige Frequenzen sind in der HF-Chirurgie üblich und geeignet, eine vorteilhafte Koagulation und Durchtrennung von Gewebe durchzuführen. Diese Frequenzen unterscheiden sich deutlich von den Frequenzen, die für die Messströme verwendet werden. Frequenzfilter können angewandt werden, um die Messspannung von der HF-Spannung zu trennen.The HF generator can be designed to provide an HF current with an AC voltage having a frequency ≥ 300 kHz, in particular ≥ 1000 kHz. Such frequencies are common in HF surgery and capable of performing advantageous coagulation and transection of tissue. These frequencies are significantly different from the frequencies used for the measurement currents. Frequency filters can be used to separate the measurement voltage from the RF voltage.

Die Kontaktmittelschicht kann eine elektrische Impedanz mit einer hohen Temperaturabhängigkeit, insbesondere mit einer (relativen) Impedanzänderung ≥ 1% pro Grad Celsius, insbesondere ≥ 2% pro Grad Celsius aufweisen. Je höher die Temperaturabhängigkeit der verwendeten Kontaktmittelschicht ist, umso einfacher lässt sich eine Temperaturänderung mittels der Impedanzänderung detektieren. Vorzugsweise ist die relative Impedanzänderung im relevanten Temperaturbereich größer als 1% pro Grad Celsius.The contact means layer can have an electrical impedance with a high temperature dependence, in particular with a (relative) impedance change ≥ 1% per degree Celsius, in particular ≥ 2% per degree Celsius. The higher the temperature dependence of the contact agent layer used, the easier it is to detect a temperature change by means of the impedance change. Preferably, the relative impedance change in the relevant temperature range is greater than 1% per degree Celsius.

Die Kontaktmittelschicht kann Hydrogel umfassen oder aus diesem bestehen. Vorzugsweise ist die Kontaktmittelschicht aus Hydrogel ausgebildet. Bei der Applikation von HF-Strom wird Hydrogel verwendet, um den Übergangswiderstand zwischen den Elektroden und der Haut zu reduzieren. Hydrogel weist bezüglich seiner Impedanz eine starke Abhängigkeit von der Temperatur auf. Daher ist Hydrogel sehr gut geeignet, um die erfindungsgemäße Temperaturermittlung vorzunehmen. Das Hydrogel hat in diesem Fall eine Doppelfunktion. Zum einen dient es zur besseren Applikation des HF-Stroms und/oder mechanischen Befestigung der Neutralelektrode am Patienten, zum anderen bildet es einen Teil eines Temperatursensors.The contact agent layer may comprise or consist of hydrogel. Preferably, the contact agent layer is formed of hydrogel. When applying RF current, hydrogel is used to reduce the contact resistance between the electrodes and the skin. Hydrogel has a strong dependence on the temperature with respect to its impedance. Therefore, hydrogel is very well suited to carry out the temperature determination according to the invention. The hydrogel has a dual function in this case. For one, it serves the better Application of the HF current and / or mechanical attachment of the neutral electrode to the patient, on the other hand, it forms part of a temperature sensor.

Die Temperaturmesseinrichtung kann eine Impedanzintegrationseinrichtung umfassen, die dazu ausgebildet ist, Impedanzänderungen über einen vorgegebenen Zeitraum zu integrieren, um Wärmebilanzschätzungen vorzunehmen. Durch eine langfristige Beobachtung (zeitliche Integration) der Impedanzänderungen über alle Aufwärm- und Abkühlphasen im Verlauf eines Eingriffs, kann eine reale Wärmebilanzschätzung durchgeführt und somit eine zuverlässige Aussage über die thermische Situation an der Neutralelektrode gemacht werden.The temperature measuring device may include an impedance integrating device configured to integrate impedance changes over a predetermined period of time to make heat balance estimates. By a long-term observation (temporal integration) of the impedance changes over all warm-up and cool-down phases in the course of an intervention, a real heat balance estimate can be made and thus a reliable statement about the thermal situation at the neutral electrode can be made.

Der vorgegebene Zeitraum kann eine Vielzahl von Aktivierungs- und Deaktivierungsphasen des HF-Generators umfassen. Somit kann sowohl die Erwärmung während der Aktivierungsphase - HF-Strom wird appliziert - wie auch die Abkühlung während der Deaktivierungsphase - kein HF-Strom wird appliziert - bei der Beurteilung der Temperatur berücksichtigt werden.The predetermined time period may include a plurality of activation and deactivation phases of the RF generator. Thus, both the heating during the activation phase - RF current is applied - as well as the cooling during the deactivation phase - no RF current is applied - are taken into account in the assessment of the temperature.

Das elektrochirurgische Gerät kann eine Erkennungsvorrichtung zur Bestimmung von Parametern, insbesondere mindestens einer Elektrodenfläche der Neutralelektrode und/oder eines Temperaturkoeffizienten umfassen. Die an einer Neutralelektrode gemessenen Impedanzwerte hängen von einer Vielzahl von Faktoren ab. Hierunter fallen die Fläche der Neutralelektrode, insbesondere die Fläche der Elektrodenabschnitte, deren Position zueinander, dem Gewebewiderstand usw. Es ist möglich, für die Berechnung der Temperatur relevante Parameter gerätespezifisch, insbesondere neutralelektrodenspezifisch, zu hinterlegen. Die Erkennungsvorrichtung kann diese Parameter bestimmen oder auslesen und in entsprechenden Modellen oder Berechnungen verarbeiten.The electrosurgical device may comprise a recognition device for determining parameters, in particular at least one electrode surface of the neutral electrode and / or a temperature coefficient. The impedance values measured at a neutral electrode depend on a variety of factors. This includes the area of the neutral electrode, in particular the area of the electrode sections, their position relative to one another, the tissue resistance, etc. It is possible to store parameters relevant to the calculation of the temperature device-specifically, in particular neutral-electrode-specific. The recognition device can determine or read these parameters and process them in corresponding models or calculations.

Die Erkennungsvorrichtung kann eine Datenbank mit einer Vielzahl von Parametern und einer Vielzahl von Neutralelektrodentypen umfassen, wobei die Erkennungsvorrichtung dazu ausgebildet ist, ein Anschließen eines bestimmten Neutralelektrodentypen zu erfassen und die Parameter demgemäß aus der Datenbank auszulesen. Die Bestimmung der angeschlossenen Neutralelektrode kann also automatisch erfolgen (z.B. über ein RFID-Tag, das sich an der Neutralelektrode befindet). Zahlreiche andere Verfahren zur Bestimmung des Neutralelektrodentypen sind denkbar. Möglich wäre es auch, den Neutralelektrodentypen vor der Behandlung manuell einzugeben oder eine Bestimmung der relevanten Parameter in einer vorgegebenen Teststellung vorzunehmen.The recognition device may include a database having a plurality of parameters and a plurality of neutral electrode types, wherein the recognition device is adapted to detect a connection of a particular type of neutral electrode and to read out the parameters from the database accordingly. The determination of the connected neutral electrode can therefore be automatic (eg via an RFID tag, which is located at the neutral electrode). Numerous other methods for determining the neutral electrode types are conceivable. It would also be possible, the neutral electrode types before treatment manually enter or make a determination of the relevant parameters in a given test position.

Das elektrochirurgische Gerät kann eine Unterbrechungseinrichtung umfassen, die dazu ausgebildet ist, beim Überschreiten eines vorgegebenen Impedanzänderung bzw. beim überschreiten einer vorgegebenen Temperatur an der Neutralelektrode den HF-Strom zu unterbrechen oder zu limitieren. Denkbar ist es auch, dass die Unterbrechungseinrichtung beim Unterschreiten eines vorgegebenen Impedanzwerts ein Warnsignal abgibt.The electrosurgical device may comprise an interrupting device which is designed to interrupt or limit the HF current when a predetermined impedance change or when exceeding a predetermined temperature at the neutral electrode is exceeded. It is also conceivable that the interruption device emits a warning signal when falling below a predetermined impedance value.

Das elektrochirurgische Gerät kann eine Kontaktmittelschicht mit derartiger Materialeigenschaft aufweisen, dass deren Impedanz mit zunehmender Temperatur abnimmt. Das heißt, es kann ein Material verwendet werden, das einen negativen Temperaturkoeffizienten hat. Somit ist es möglich, entlang der großflächigen Neutralelektrode Abschnitte mit besonders geringem Widerstand bedingt durch besonders hohe Temperaturen zu erfassen.The electrosurgical device can have a contact agent layer with such a material property that its impedance decreases with increasing temperature. That is, a material having a negative temperature coefficient can be used. Thus, it is possible to detect along the large-area neutral electrode sections with very low resistance due to particularly high temperatures.

Die Temperaturmesseinrichtung zur Bestimmung der Temperatur und/oder der Temperaturänderung kann den Effektivwert des HF-Stroms, insbesondere des applizierten HF-Stroms, berücksichtigen. Beispielsweise ist es möglich, eine Relation zwischen Impedanzänderung und Effektivwert zu berechnen (z. B. ΔR/IHF), um eine Temperaturänderung und/oder einen Widerstand, insbesondere einen Gewebewiderstand oder einen Übergangswiderstand zwischen Elektrode und Gewebe, zu ermitteln. Der Widerstand kann unter anderem darüber Aufschluss geben, wie gut eine Neutralelektrode am Gewebe anliegt.The temperature measuring device for determining the temperature and / or the temperature change can take into account the effective value of the HF current, in particular of the applied HF current. For example, it is possible to calculate a relation between impedance change and effective value (eg ΔR / I HF ) in order to determine a temperature change and / or a resistance, in particular a tissue resistance or a contact resistance between electrode and tissue. Among other things, the resistance can reveal how well a neutral electrode rests against the tissue.

Das elektrochirurgische Gerät umfaßt eine Stromintegrationseinrichtung, die erfindungsgemäß dazu ausgebildet ist, einen Wert bezüglich des HF-Stroms, insbesondere den Effektivwert, über die Zeit, insbesondere einen vorgegebenen Zeitraum aufzusummieren, und die Summe zur Bestimmung der Temperatur und/oder der Temperaturänderung mit einer Impedanzänderung in Beziehung zu setzen. Es ist einfacher und mit geringern Fehlern behaftet, wenn sowohl die Impedanzänderung wie auch die Summe des applizierten HF-Stroms über ein vorgegebenes Zeitintervall betrachtet wird. Die einzelnen Werte können in Relation gesetzt werden (z. B. ΔR/ΣIHF), um Kenngrößen des Systems zu erfassen und Temperatur und/oder Temperaturänderungen festzustellen.The electrosurgical device comprises a current integrating device, which according to the invention is designed to sum up a value with respect to the HF current, in particular the RMS value, over time, in particular a predetermined period, and the sum for determining the temperature and / or the temperature change with an impedance change to relate to. It is simpler and less flawed if both the impedance change and the sum of the applied RF current are considered over a given time interval. The individual values can be related (eg, ΔR / ΣI HF ) to capture system characteristics and determine temperature and / or temperature changes.

Ein Verfahren zur Bestimmung einer Temperatur und/oder einer Temperaturänderung an einer Neutralelektrode mit einer Kontaktmittelschicht wird offenbart wobei das Verfahren die folgenden Schritte umfasst:

  1. a) Bestimmen mindestens eines Impedanzwerts der Kontaktmittelschicht;
  2. b) Berechnen einer Temperaturänderung und/oder einer Temperatur an der Neutralelektrode mindestens anhand des Impedanzwerts.
A method for determining a temperature and / or a temperature change at a neutral electrode with a contact agent layer is disclosed, wherein the method comprises the following steps:
  1. a) determining at least one impedance value of the contact agent layer;
  2. b) calculating a temperature change and / or a temperature at the neutral electrode based at least on the impedance value.

Auch das Verfahren nutzt die Abhängigkeit der Impedanz der Kontaktmittelschicht von der vorliegenden Temperatur. Der unmittelbaren Nachbarschaft zwischen Kontaktmittelschicht und dem applizierenden Teil der Neutralelektrode wegen sowie der Nachbarschaft zwischen der Kontaktmittelschicht und dem Gewebe wegen findet ein schneller Wärmeaustausch statt. Es kann davon ausgegangen werden, dass die Gewebetemperatur des Gewebes, das unmittelbar unterhalb der Neutralelektrode liegt, im Wesentlichen gleich der Temperatur der Neutralelektrode und der Kontaktmittelschicht ist. Somit lässt sich eine realistische Abschätzung der Temperaturbilanz an der Neutralelektrode durchführen. Ein unzulässig starkes Erhöhen der Temperatur aufgrund des applizierten HF-Stroms kann erkannt und unterbunden werden.The method also makes use of the dependence of the impedance of the contact agent layer on the present temperature. Because of the immediate neighborhood between the contact agent layer and the applying part of the neutral electrode, as well as the neighborhood between the contact agent layer and the tissue, a quick heat exchange takes place. It can be considered that the tissue temperature of the tissue immediately below the neutral electrode is substantially equal to the temperature of the neutral electrode and the contact agent layer. This makes it possible to carry out a realistic estimation of the temperature balance at the neutral electrode. An inadmissibly high temperature increase due to the applied HF current can be detected and prevented.

Der Schritt a) kann mehrfach während einer Vielzahl von Aktivierungs- und Deaktivierungsphasen erfolgen, um eine Vielzahl von Impedanzwerten zu ermitteln. Somit kann der Temperaturverlauf bzw. die einzelnen Temperaturveränderungen an der Neutralelektrode besser beurteilt werden. Es kann eine realistische Abschätzung der vorliegenden Temperatur durchgeführt werden.Step a) may be performed multiple times during a plurality of activation and deactivation phases to determine a plurality of impedance values. Thus, the temperature profile or the individual temperature changes at the neutral electrode can be better assessed. A realistic estimate of the present temperature can be made.

Bei dem Schritt b) kann die Dauer der Aktivierungs- und/oder Deaktivierungsphase und/oder ein Effektivwert des HF-Stroms berücksichtigt werden.In step b), the duration of the activation and / or deactivation phase and / or an effective value of the HF current can be taken into account.

Der Schritt b) kann eine Integration über eine Vielzahl von Impedanzwerten über die Zeit umfassen.Step b) may include integration over a plurality of impedance values over time.

Das Verfahren kann ein Erfassen einer Impedanzänderung während einer Aktivierungs- und/oder Deaktivierungsphase umfassen. Beispielsweise ist es möglich, anhand des Quotienten zwischen Abkühlungszeit und Impedanzänderung Rückschlüsse auf die vorliegende Temperatur zu ziehen. Es kann wohl davon ausgegangen werden, dass die Neutralelektrode bei einem starken Temperaturgefälle zwischen Neutralelektrode und Umgebung schneller abkühlt. Die Impedanzänderung in Relation zur Zeit kann somit einen wichtigen Parameter zur Bestimmung der Temperatur bereitstellen.The method may include detecting an impedance change during an activation and / or deactivation phase. For example, it is possible to use the quotient between cooling time and impedance change to draw conclusions about the present temperature. It can probably be assumed that the neutral electrode cools faster at a strong temperature gradient between the neutral electrode and the environment. The change in impedance relative to time can thus provide an important parameter for determining the temperature.

Die Berechnung der Temperaturänderung kann eine lineare Abschätzung umfassen, insbesondere mittels der Formel: Δ T = R T - R T 0 α * R T 0 ,

Figure imgb0001

wobei

α :
ein spezifischer Temperaturkoeffizient,
T 0:
eine Ausgangstemperatur,
R(T 0):
eine Impedanz bei der Ausgangstemperatur T 0,
R(T):
die gemessene Impedanz ist.
The calculation of the temperature change may comprise a linear estimation, in particular by means of the formula: Δ T = R T - R T 0 α * R T 0 .
Figure imgb0001

in which
α :
a specific temperature coefficient,
T 0 :
a starting temperature,
R ( T 0 ):
an impedance at the starting temperature T 0 ,
R ( T ):
the measured impedance is.

Obwohl eine lineare Relation zwischen Temperatur und Impedanz bei dem verwendeten Kontaktmittel, vorzugsweise Hydrogel, nicht vorliegt, kann die Veränderung der Impedanz in Abhängigkeit zur Temperatur durch eine lineare Gleichung ausreichend genau angenähert werden. Alternativ können Polynomgleichungen mit einem höheren Grad zur Annäherung verwendet werden. Der spezifische Temperaturkoeffizient kann vorab in entsprechenden Teststellungen ermittelt werden. Denkbar ist es auch, eine Vielzahl von Temperaturkoeffizienten für eine Polynomgleichung mit einem höheren Grad zu ermitteln.Although a linear relationship between temperature and impedance is not present in the contact means used, preferably hydrogel, the change in impedance as a function of temperature can be approximated sufficiently accurately by a linear equation. Alternatively, polynomial equations with a higher degree can be used for approximation. The specific temperature coefficient can be determined in advance in corresponding test positions. It is also conceivable to determine a multiplicity of temperature coefficients for a polynomial equation with a higher degree.

Das Verfahren kann umfassen:

  • Ein Detektieren eines bestimmten Neutralelektrodentypen der angeschlossenen Neutralelektrode;
  • Eine Auswahl eines vorgegebenen Temperaturkoeffizienten oder eines beliebigen anderen Parameters gemäß dem Neutralelektrodentypen.
The method may include:
  • Detecting a particular neutral electrode type of the connected neutral electrode;
  • A selection of a given temperature coefficient or any other parameter according to the neutral electrode type.

Somit können vorab ermittelte Parameter automatisch in das Verfahren eingebunden werden.Thus, previously determined parameters can be automatically included in the process.

Das Verfahren kann ein Ausgeben eines Warnsignals und/oder ein Abschalten oder Herunterregeln des HF-Stroms umfassen, wenn die gemessene Impedanzänderung einen vorgegebenen Grenzwert überschreitet. Somit kann bei einer unzulässigen Temperatur eine Warnmeldung ausgegeben, der HF-Strom unterbrochen oder limitiert werden, um eine Schädigung des Patienten auszuschließen.The method may include outputting a warning signal and / or shutting off or shutting down the RF current if the measured impedance change exceeds a predetermined limit. Thus, in the event of an impermissible temperature, a warning message can be output, the HF current can be interrupted or limited in order to preclude any damage to the patient.

Nachfolgend wird die Erfindung anhand von einigen Ausführungsbeispielen beschrieben, die mittels Abbildungen näher erläutert werden. Hierbei zeigen:

  • Fig. 1 ein HF-Generatorsystem mit einem monopolaren Instrument;
  • Fig. 2 Komponenten des HF-Generatorsystems;
  • Fig. 3 Widerstands- und Stromverhältnisse an einer Neutralelektrode; und
  • Fig. 4 ein Diagramm mit idealisierten Widerstands-Temperaturverläufen.
The invention will be described with reference to some embodiments, which are explained in more detail by means of illustrations. Hereby show:
  • Fig. 1 an RF generator system with a monopolar instrument;
  • Fig. 2 Components of the RF generator system;
  • Fig. 3 Resistance and current conditions at a neutral electrode; and
  • Fig. 4 a diagram with idealized resistance-temperature curves.

In der nachfolgenden Beschreibung werden für gleiche und gleich wirkende Teile dieselben Bezugsziffern verwendet.In the following description, the same reference numerals are used for the same and like parts.

Die Fig. 1 zeigt ein elektrochirurgisches Gerät, umfassend ein HF-Generatorsystem 30, ein monopolares Instrument 20 und eine Neutralelektrode 10. Das HF-Generatorsystem 30 stellt einen HF-Strom IHF bereit, der mittels des monopolaren Instruments 20 und der Neutralelektrode 10 an einen Torso 1 appliziert wird. Die Fig. 1 stellt einen schematischen Querschnitt durch diesen Torso 1 dar. Die Neutralelektrode 10 ist großflächig an den Torso 1 angebracht. Das monopolare Instrument 20 beherbergt eine Aktivelektrode, die eine wesentlich geringere Fläche als die Neutralelektrode 10 aufweist. Der Strom fließt von der Aktivelektrode zur Neutralektrode. In unmittelbarer Nähe der Aktivelektrode ist die Stromdichte so hoch, dass eine gezielte Koagulation oder Durchtrennung von Gewebe 3 (vgl. Fig. 3) durchgeführt werden kann.The Fig. 1 shows an electrosurgical device comprising an RF generator system 30, a monopolar instrument 20 and a neutral electrode 10. The RF generator system 30 provides an RF current I HF which is applied by means of the monopolar instrument 20 and the neutral electrode 10 to a torso 1 becomes. The Fig. 1 represents a schematic cross section through this torso 1. The neutral electrode 10 is attached to the torso 1 over a large area. The monopolar instrument 20 accommodates an active electrode which has a substantially smaller area than the neutral electrode 10. The current flows from the active electrode to the neutral electrode. In the immediate vicinity of the active electrode, the current density is so high that a targeted coagulation or separation of tissue 3 (see. Fig. 3 ) can be carried out.

Fig. 2 zeigt wesentliche Komponenten des HF-Generatorsystems 30. Diese umfassen eine Steuereinrichtung 36, eine Anzeigeeinrichtung 32, eine Bedieneinrichtung 34 und eine Messeinrichtung 37. Der Benutzer des elektrochirurgischen Geräts kann über die Bedieneinrichtung 34 den HF-Strom IHF aktivieren oder deaktivieren. Des Weiteren ist es möglich, verschiedene Betriebsmodi, beispielsweise einen zum Schneiden von Gewebe und einen anderen zum Koagulieren desselben einzustellen. Je nach den Eingaben des Benutzers, steuert die Steuereinrichtung 36 den HF-Generator 31, der einen HF-Strom IHF den Vorgaben entsprechend bereitstellt. Die Anzeigeeinrichtung 32 kann dazu verwendet werden, eingestellte Parameter, beispielsweise den aktuellen Betriebsmodus anzuzeigen. Des Weiteren kann die Anzeigeeinrichtung 32 eine aktuell an der Neutralelektrode 10 vorliegende Temperatur anzeigen und Warnhinweise ausgeben, die den Patienten vor einer ungewollten Schädigung durch die Behandlung schützen. Erfindungsgemäß wird die Temperatur der Neutralelektrode 10 durch die Messeinrichtung 37 unter Verwendung einer Sekundärstromquelle 38 ermittelt. Sobald die Neutralelektrode 10 eine Temperatur hat, die möglicherweise zu Verbrennungen führen könnte, wird der HF-Generator 31 abgeschaltet und die Anzeigeeinrichtung 32 gibt entsprechende Warnhinweise aus. Fig. 2 3 shows essential components of the HF generator system 30. These include a control device 36, a display device 32, an operating device 34 and a measuring device 37. The user of the electrosurgical device can activate or deactivate the HF current I HF via the operating device 34. Furthermore, it is possible to set various modes of operation, such as one for cutting tissue and another for coagulating it. Depending on the inputs of the user, the controller 36 controls the RF generator 31, which provides an RF current I HF according to the specifications. The display 32 may be used to display set parameters, such as the current operating mode. Furthermore, the display device 32 can display a temperature currently present at the neutral electrode 10 and issue warnings that protect the patient from undesired damage from the treatment. According to the invention, the temperature of the neutral electrode 10 is determined by the measuring device 37 using a secondary current source 38. Once the neutral electrode 10 has a temperature that could possibly lead to burns, the RF generator 31 is turned off and the display 32 issues corresponding warnings.

In einem Ausführungsbeispiel der erfindungsgemäßen Neutralelektrode 10 (vgl. Fig. 3) umfasst diese einen ersten Elektrodenabschnitt 11 und einen zweiten Elektrodenabschnitt 11'. Die Elektrodenabschnitte 11, 11' sind auf einem Trägermaterial derart angeordnet, dass diese gegeneinander elektrisch isoliert sind.In one embodiment of the neutral electrode 10 according to the invention (see. Fig. 3 ) comprises a first electrode section 11 and a second electrode section 11 '. The electrode sections 11, 11 'are arranged on a carrier material in such a way that they are electrically insulated from one another.

In einer Ausgestaltung der Neutralelektrode 10 befindet sich zwischen den einzelnen Elektrodenabschnitten 11, 11' ein elektrischer Isolator oder Hydrogel 13. Im vorliegenden Ausführungsbeispiel handelt es sich um eine selbstklebende Neutralelektrode 10, die eine Schicht aus elektrisch leitfähigem Hydrogel 13 aufweist und zur Applikation des HF-Stroms IHF auf ein Gewebe 3 aufgeklebt ist. Die vorliegende Erfindung macht es sich zu Nutzen, dass das Hydrogel 13 einen starken Temperaturkoeffizienten der Impedanz hat. Beispielsweise wurde bei handelsüblichen Neutralelektroden 10 mit handelsüblichem Hydrogel 13 im Temperaturbereich von 25°C bis 40°C eine relative Impedanzänderung von 2 bis 4% pro Grad Celsius gemessen. Dieser Effekt kann zur Bestimmung der Temperaturerhöhung an der Neutralelektrode 10 genutzt werden. Hierbei müssen allerdings verschiedene weitere Parameter berücksichtigt werden. Beispielsweise haben die Umgebungsbedingungen einen starken Einfluss auf die gemessene Impedanz R(T).In one embodiment of the neutral electrode 10 is located between the individual electrode sections 11, 11 ', an electrical insulator or hydrogel 13. In the present embodiment, it is a self-adhesive neutral electrode 10 having a layer of electrically conductive hydrogel 13 and for application of the HF Current I HF is glued to a fabric 3. The present invention takes advantage of the fact that the hydrogel 13 has a strong temperature coefficient of impedance. For example, commercially available neutral electrodes 10 were measured with commercial hydrogel 13 in the temperature range of 25 ° C to 40 ° C, a relative impedance change of 2 to 4% per degree Celsius. This effect can be used to determine the temperature increase at the neutral electrode 10. Here, however, various other parameters must be considered. For example, the environmental conditions have a strong influence on the measured impedance R (T).

Zur Messung der von der Temperatur T abhängigen Impedanz R (T) umfasst die Messeinrichtung 37 die Sekundärstromquelle 38. Diese stellt einen Messstrom IMess bereit, der an den Elektrodenabschnitten 11, 11' angelegt wird. Mittels einer parallel zur Sekundärstromquelle 38 geschalteten Spannungsmesseinrichtung 39 lässt sich eine Messspannung UMess ermitteln. Somit kann die Messeinrichtung 37 eine Gesamtimpedanz messen. In einem ersten Modell wird davon ausgegangen, dass sich diese Gesamtimpedanz, wie in der Fig. 3 gezeigt, aus mehreren Widerständen zusammensetzt. So durchläuft der Messstrom IMess von dem ersten Elektrodenabschnitt 11 das Hydrogel 13, tritt zumindest teilweise in das Gewebe 3 ein, durchläuft erneut das Hydrogel 13 und erreicht den zweiten Elektrodenabschnitt 11'. Die Gesamtimpedanz setzt sich also zumindest aus einem Gelwiderstand RGel1, einem Gewebewiderstand RGewebe und einem zweiten Gelwiderstand RGel2 zusammen.In order to measure the impedance R (T) dependent on the temperature T, the measuring device 37 comprises the secondary current source 38. This device provides a measuring current I measuring which is applied to the electrode sections 11, 11 '. By means of a parallel to the secondary power source 38 connected voltage measuring device 39 can be a measurement voltage U detected measurement . Thus, the measuring device 37 can measure an overall impedance. In a first model it is assumed that this total impedance, as in the Fig. 3 shown, composed of several resistors. Thus, the measuring current I measurement of the first electrode section 11 passes through the hydrogel 13, at least partially enters the tissue 3, again passes through the hydrogel 13 and reaches the second electrode section 11 '. The total impedance is thus composed at least of a gel resistance R Gel1 , a tissue resistance R tissue and a second gel resistance R Gel2 .

In dem ersten Modell kann davon ausgegangen werden, dass die Gewebewiderstandänderung im relevanten Temperaturenbereich (ca. 20 bis 70°) vernachlässigt werden kann. Die Messeinrichtung 37 kann die Gelwiderstände RGel1, RGel2 mittels des Messstroms IMess ermitteln. Der Gewebewiderstand RGewebe kann durch weitere Messungen ermittelt werden oder auf einen konstanten Wert gesetzt werden, der in Gewebe üblicherweise auftretenden ungefähren Widerständen entspricht.In the first model it can be assumed that the tissue resistance change in the relevant temperature range (about 20 to 70 °) can be neglected. The measuring device 37 can determine the gel resistances R Gel1 , R Gel2 by means of the measuring current I Mess . The tissue resistance R tissue can be determined by further measurements or set to a constant value which corresponds to approximate resistances commonly encountered in tissue.

In einem zweiten Modell geht man davon aus, dass die Gelwiderstände RGel1, RGel2 geringer sind als der Gewebewiderstand RGewebe, so dass die Messung der Messeinrichtung 37 ausschließlich die Veränderungen der Impedanz R(T) des Hydrogels 13 erfasst. Es ist möglich ein Hydrogel 13 entsprechend auszuwählen.In a second model, it is assumed that the gel resistances R Gel1 , R Gel2 are less than the tissue resistance R tissue , so that the measurement of the measuring device 37 exclusively detects the changes in the impedance R (T) of the hydrogel 13. It is possible to select a hydrogel 13 accordingly.

In einem dritten Modell, das wohl die Realität bei der Verwendung eines üblichen Hydrogels 13 am besten modelliert, unterstellt man, dass der Widerstand des Hydrogels 13 größer ist als der des Gewebes 3. Insbesondere wegen der geringen Schichtdicke des Hydrogels 13 kann dies in der Realität häufig auftreten. Experimente haben ergeben, dass 30% des Stromflusses innerhalb der Hydrogelschicht stattfindet während 70% des Stromflusses im Gewebe stattfindet. Es sind Situationen denkbar, bei denen nur ca. 10% des Stromflusses im Hydrogel 13 stattfindet. Die Impedanz R (T) setzt sich also, wie in Fig. 3 gezeigt, aus den Gelwiderständen RGel1, RGel2 und dem Gewebewiderstand RGewebe zusammen. Da sich die Gewebetemperatur bei der Applikation des HF-Stroms IHF im Vergleich zu der Temperatur des Hydrogels 13 nur sehr langsam verändert - die Blutzirkulation führt zu einem schnellen Abtransport der anfallenden Wärmeenergie - kann auch bei diesem Modell ein konstanter oder annähernd konstanter Wert für RGewebe unterstellt werden. Auf die Impedanzänderung Δ R hat die Temperatur des Gewebes 3 nur einen geringen Einfluss. Diese lässt sich also erfindungsgemäß erfassen.In a third model, which probably best models the reality when using a conventional hydrogel 13, it is assumed that the resistance of the hydrogel 13 is greater than that of the tissue 3. In particular, because of the small layer thickness of the hydrogel 13, this can be done in reality often occur. Experiments have shown that 30% of the flow of current takes place within the hydrogel layer while 70% of the flow of current takes place in the tissue. Situations are conceivable in which only about 10% of the flow of current takes place in the hydrogel 13. The impedance R (T) thus settles, as in Fig. 3 shown, from the gel resistors R Gel1 , R Gel2 and the tissue resistance R tissue together. Since the tissue temperature in the application of the HF current I HF compared to the temperature of the hydrogel 13 only changed very slowly - the blood circulation leads to a fast removal of the accumulating heat energy - can be assumed in this model, a constant or approximately constant value for R tissue . On the impedance change Δ R , the temperature of the fabric 3 has only a small influence. This can thus be detected according to the invention.

Da die Gelwiderstände RGel1, RGel2 mit zunehmender Temperatur T stark abnehmen, stellt sich ein weiterer vorteilhafter Effekt ein. Bei einer punktuellen oder lokalen Erwärmung der Neutralelektrode 10 kann ein starker Abfall der gemessenen Impedanz R(T) in diesem Bereich detektiert werden.Since the gel resistances R Gel1 , R Gel2 decrease sharply with increasing temperature T, a further advantageous effect arises. If the neutral electrode 10 is locally or locally heated, a sharp drop in the measured impedance R (T) in this region can be detected.

Der thermische Effekt, der sowohl im Gewebe 3 als auch im Hydrogel 13 und an der Neutralelektrode 10 auftritt, ist auf den angelegten HF-Strom IHF zurückzuführen. Bei der Verwendung von zwei Elektrodenabschnitten 11, 11' teilt sich dieser HF-Strom IHF in zwei HF-Teilströme IHF1, IHF2 auf. Diese HF-Teilströme IHF1, IHF2 sind schematisch in der Fig. 3 dargestellt.The thermal effect that occurs in both the fabric 3 and the hydrogel 13 and at the neutral electrode 10 is due to the applied RF current I HF . When two electrode sections 11, 11 'are used, this HF current I HF divides into two HF substreams I HF1 , I HF2 . These HF partial currents I HF1 , I HF2 are shown schematically in FIG Fig. 3 shown.

In diesem Ausführungsbeispiel wird davon ausgegangen, dass sich die Beziehung zwischen der Impedanz R(T) des Hydrogels 13 und dessen Temperatur T mit einem Temperaturkoeffizienten erster Ordnung α ausreichend genau modellieren lässt. Alternativ können Temperaturkoeffizienten höherer Ordnung hinzugenommen werden.In this embodiment, it is considered that the relationship between the impedance R (T) of the hydrogel 13 and its temperature T can be modeled sufficiently accurately with a first-order temperature coefficient α . Alternatively, higher order temperature coefficients can be added.

Mathematisch betrachtet stellt sich die Temperaturänderung Δ T wie folgt dar: Δ T = R T - R T 0 α * R T 0

Figure imgb0002
Mathematically, the temperature change Δ T is as follows: Δ T = R T - R T 0 α * R T 0
Figure imgb0002

Hierbei ist R(T) die gemessene Impedanz bei der Temperatur T, R(T0) eine Impedanz bei einer Ausgangstemperatur T0 und α der spezifischer Temperaturkoeffizient. Der spezifische Temperaturkoeffizient α lässt sich beispielsweise innerhalb eines Testaufbaus ermitteln.Here, R (T) is the measured impedance at the temperature T, R (T 0 ) is an impedance at an output temperature T 0 and α is the specific temperature coefficient. The specific temperature coefficient α can be determined, for example, within a test setup.

Anhand des Diagramms aus Fig. 4 wird die erfindungsgemäße Funktionsweise der Messeinrichtung 37 beschrieben.Look at the diagram Fig. 4 the operation of the measuring device 37 according to the invention will be described.

Die X-Achse gibt den Verlauf der Zeit t in Sekunden an. Die Y-Achse gibt Impedanzwerte R1, R2, R3, R4 einer gemessenen Impedanz R(T) in Ohm (untere Linie) und eine an der Neutralelektrode 10 vorliegende Temperatur T(t) (obere Linie) in Grad Celsius an. Während in Y-Richtung die Temperaturwerte T1, T2, T3, T4 abnehmen, nehmen die Impedanzwerte R1, R2, R3, R4 entlang der Y-Richtung zu.The X-axis indicates the course of time t in seconds. The Y-axis gives impedance values R 1 , R 2 , R 3 , R 4 of a measured impedance R (T) in ohms (lower Line) and a temperature T (t) (upper line) present at the neutral electrode 10 in degrees Celsius. While the temperature values T 1 , T 2 , T 3 , T 4 decrease in the Y direction, the impedance values R 1 , R 2 , R 3 , R 4 increase along the Y direction.

Das Diagramm zeigt beispielhaft den Verlauf einer HF-Behandlung mit einer erfindungsgemäßen Neutralelektrode 10. Unmittelbar nach dem Aufbringen der Neutralelektrode 10 stellt sich in dem Hydrogel 13 der erste Temperaturwert T1 ein. Der erste Temperaturwert T1 entspricht im Wesentlichen der Körperoberflächentemperatur von ca. 32 ° C. Die Messeinrichtung 37 kann den ersten Impedanzwert R1 erfassen. Zum Zeitpunkt t1 wird der HF-Generator 31 mit einer geringen Leistung aktiviert (Schematisch durch die Rampe im Diagramm dargestellt). Die Aktivierungsphase dauert bis zu dem Zeitpunkt t2. Während der Aktivierungsphase sinkt die gemessene Impedanz R(T) auf den Impedanzwert R3. Da der Messeinrichtung 37 die Ausgangstemperatur T1, die Ausgangsimpedanz R1 und der Impedanzwert R3 zum Zeitpunkt t2 bekannt ist, kann sie mittels der oben genannten Formel die Temperaturänderung ΔT berechnen. Anhand dieser lässt sich der absolute Temperaturwert T3 ermitteln.The diagram shows an example of the course of an HF treatment with a neutral electrode 10 according to the invention. Immediately after the application of the neutral electrode 10, the first temperature value T 1 is established in the hydrogel 13. The first temperature value T 1 essentially corresponds to the body surface temperature of approximately 32 ° C. The measuring device 37 can detect the first impedance value R 1 . At time t 1 , the HF generator 31 is activated with a low power (shown schematically by the ramp in the diagram). The activation phase lasts until time t 2 . During the activation phase, the measured impedance R (T) drops to the impedance value R 3 . Since the measuring device 37, the output temperature T 1 , the output impedance R 1 and the impedance value R 3 at time t 2 is known, it can calculate the temperature change .DELTA.T by means of the above-mentioned formula. Based on this, the absolute temperature value T 3 can be determined.

Während einer Deaktivierungsphase (Zeitpunkt t2 bis t3) steigt die gemessene Impedanz R(T). Auch hier lässt sich die Temperaturänderung Δ T anhand der Impedanzänderung ΔR ermitteln, da R2 messbar ist und R3, T3 bekannt sind. Die Messeinrichtung 37 kann also die Temperatur T2 aus der aktuellen Temperaturänderung ΔT errechnen. In einer folgenden Aktivierungsphase des HF-Generators 31 (Zeitraum t3 bis t4) steigt die Temperatur der Neutralelektrode T(t) erneut an. Auch hier lässt sich die Temperaturänderung ΔT berechnen.During a deactivation phase (time t 2 to t 3 ), the measured impedance R (T) increases. Again, the temperature change Δ T can be determined based on the impedance change ΔR, since R 2 is measurable and R 3 , T 3 are known. The measuring device 37 can therefore calculate the temperature T 2 from the current temperature change ΔT. In a subsequent activation phase of the HF generator 31 (time period t 3 to t 4 ), the temperature of the neutral electrode T (t) rises again. Again, the temperature change ΔT can be calculated.

Vorab wurde ein Ausführungsbeispiel zur erfindungsgemäßen Bestimmung der Temperatur T(t) und der Temperaturänderung Δ T an der Neutralelektrode 10 beschrieben.An exemplary embodiment for determining the temperature T (t) according to the invention and the temperature change ΔT at the neutral electrode 10 has been described above.

In weiteren Ausführungsbeispielen können weitere Parameter verarbeitet werden. Beispielsweise ist es denkbar, die Temperaturänderung ΔT während eines Zeitintervalls zu berücksichtigen. So kann ein starker Temperaturabfall während einer relativ kurzen Deaktivierungsphase als Indikator verwendet werden, dass eine relativ hohe Temperatur T(t) an der Neutralelektrode 10 vorliegt, da wohl ein starkes Temperaturgefälle zur Umgebung vorliegt. Zahlreiche weitere Verfahren sind denkbar, die den Effekt ausnützen, dass eine unmittelbare Korrelation zwischen der Impedanzänderung Δ R des Hydrogels 13 und dessen Temperaturänderung Δ T vorliegt.In further embodiments, further parameters can be processed. For example, it is conceivable to take into account the temperature change ΔT during a time interval. Thus, a strong drop in temperature during a relatively short deactivation phase can be used as an indicator that a relatively high temperature T (t) is present at the neutral electrode 10, since there is probably a strong temperature gradient to the environment. Numerous other methods are conceivable which exploit the effect that a direct correlation between the Impedance change Δ R of the hydrogel 13 and its temperature change Δ T is present.

BezugszeichenlisteLIST OF REFERENCE NUMBERS

11
Torsotorso
33
Gewebetissue
1010
Neutralelektrodeneutral electrode
11, 11'11, 11 '
Elektrodenabschnittelectrode section
1313
Hydrogelhydrogel
2020
monopolares Instrumentmonopolar instrument
3030
HF-GeneratorsystemRF generator system
3131
HF-GeneratorRF generator
3232
Anzeigeeinrichtungdisplay
3434
Bedieneinrichtungoperating device
3636
Steuereinrichtungcontrol device
3737
Messeinrichtungmeasuring device
3838
SekundärstromquelleSecondary power source
3939
SpannungsmesseinrichtungVoltage measuring device
ΔR.DELTA.R
Impedanzänderungimpedance change
ΔT.DELTA.T
Temperaturänderungtemperature change
T(t)T (t)
Temperatur der NeutralelektrodeTemperature of the neutral electrode
R(T)R (T)
Impedanzimpedance
IMess I mess
Messstrommeasuring current
UMess U Mess
Messspannungmeasuring voltage
RGel1, RGel2 R Gel1 , R Gel2
GelwiderstandGelwiderstand
RGewebe R tissue
Gewebewiderstandtissue resistance
IHF I HF
HF-StromRF power
IHF1, IHF2 I HF1 , I HF2
HF-TeilstromRF partial flow
t1, t2, t3, t4, t5 t 1 , t 2 , t 3 , t 4 , t 5
Zeitpunkttime
T1, T2, T3, T4 T 1 , T 2 , T 3 , T 4
Temperaturwerttemperature value
R1, R2, R3, R4 R 1 , R 2 , R 3 , R 4
Impedanzwerteimpedance values
TT
Temperaturtemperature
αα
Temperaturkoeffizienttemperature coefficient

Claims (14)

  1. Electrosurgical device, comprising:
    - an RF generator (31) for generating an RF current (IHF), which can be introduced into biological tissue (3) via an instrument (20) and a neutral electrode (10) with a contact agent layer (13) ;
    - a temperature measuring apparatus (37) for determining a temperature and/or a change in temperature (ΔT) at the neutral electrode (10); the temperature measuring apparatus (37) comprising an impedance measuring apparatus for determining the temperature and/or the change in temperature (ΔT), said impedance measuring apparatus being embodied to register an impedance (R(T)) of the contact agent layer (13),
    the impedance measuring apparatus comprising a measurement current generator, which is embodied to provide a measurement current (IMess) at a first electrode section (11) and a second electrode section (11'),
    characterized by
    a current integration apparatus, which is embodied to sum a value in respect of the RF current (IHF) over time and to relate this value to a change in impedance (ΔR) in order to determine the temperature and/or the change in temperature (ΔT).
  2. Electrosurgical device according to Claim 1,
    characterized in that
    the measurement current generator is embodied to provide the measurement current (IMess) with an AC voltage, in particular with a frequency of less than or equal to 300 kHz, in particular of less than or equal to 150 kHz, in particular of less than or equal to 100 kHz.
  3. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the electrode sections (11, 11') are arranged on the contact agent layer (13) in a manner electrically insulated from one another.
  4. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the RF generator (31) is embodied to provide an RF current (IHF) with an AC voltage with a frequency of greater than or equal to 300 kHz, in particular of greater than or equal to 1000 kHz.
  5. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the contact agent layer (13) has an electrical impedance with a temperature dependence, in particular with a relative change in impedance of greater than or equal to 1% per degree centigrade, in particular of greater than or equal to 2% per degree centigrade.
  6. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the contact agent layer (13) comprises a hydrogel.
  7. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the temperature measuring apparatus (37) comprises an impedance integration apparatus, which is embodied to integrate changes in impedance (ΔR) over a predetermined period of time in order to perform a heat balance estimate.
  8. Electrosurgical device according to Claim 7,
    characterized in that
    the predetermined period of time comprises a multiplicity of activation and deactivation phases of the RF generator (31).
  9. Electrosurgical device according to one of the preceding claims,
    characterized by
    identification equipment for determining parameters, in particular of at least one electrode area of the neutral electrode (10) and/or of a temperature coefficient (α).
  10. Electrosurgical device according to Claim 9,
    characterized in that
    the identification equipment comprises a database with a multiplicity of parameters and a multiplicity of neutral electrode types, the identification equipment being embodied to register a specific neutral electrode type being connected and accordingly read out the parameters from the database.
  11. Electrosurgical device according to one of the preceding claims,
    characterized by
    a cut-off apparatus, which is embodied to cut off or limit the RF current (IHF) when a predetermined change in impedance is exceeded.
  12. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the contact agent layer (13) has such a material property that the impedance thereof decreases with increasing temperature.
  13. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the temperature measuring apparatus (37) for determining the temperature and/or the change in temperature takes the effective value of the RF current (IHF) into account.
  14. Electrosurgical device according to one of the preceding claims,
    characterized in that
    the current integration apparatus is embodied to sum the effective value of the RF current (IHF) over time.
EP09743877.4A 2008-10-30 2009-10-28 Electrosurgical device having a temperature measurement device for determining a temperature and/or a temperature change at a neutral electrode Active EP2367493B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL09743877T PL2367493T3 (en) 2008-10-30 2009-10-28 Electrosurgical device having a temperature measurement device for determining a temperature and/or a temperature change at a neutral electrode

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008053841 2008-10-30
DE102009013917A DE102009013917A1 (en) 2008-10-30 2009-03-19 Electrosurgical device with a temperature measuring device, method for determining a temperature and / or a temperature change at a neutral electrode
PCT/EP2009/007722 WO2010049145A1 (en) 2008-10-30 2009-10-28 Electrosurgical device having a temperature measurement device, method for determining a temperature and/or a temperature change at a neutral electrode

Publications (2)

Publication Number Publication Date
EP2367493A1 EP2367493A1 (en) 2011-09-28
EP2367493B1 true EP2367493B1 (en) 2014-08-27

Family

ID=42096555

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09743877.4A Active EP2367493B1 (en) 2008-10-30 2009-10-28 Electrosurgical device having a temperature measurement device for determining a temperature and/or a temperature change at a neutral electrode

Country Status (7)

Country Link
US (1) US9289254B2 (en)
EP (1) EP2367493B1 (en)
JP (1) JP5476390B2 (en)
CN (1) CN102202592B (en)
DE (1) DE102009013917A1 (en)
PL (1) PL2367493T3 (en)
WO (1) WO2010049145A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10350709A1 (en) 2003-10-30 2005-08-18 Erbe Elektromedizin Gmbh Device for coagulation of tissue
DE102008046300A1 (en) * 2008-09-09 2010-03-18 Erbe Elektromedizin Gmbh Neutral electrode device, electrosurgical instrument with corresponding neutral electrode device, contact means and use of a latent heat storage for cooling an electrode
US10441354B2 (en) * 2016-01-25 2019-10-15 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation
US10292763B2 (en) 2016-01-25 2019-05-21 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation
US10405920B2 (en) 2016-01-25 2019-09-10 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation
PL2537479T3 (en) * 2011-06-20 2014-08-29 Erbe Elektromedizin Controlling a medical device depending on neutral electrode impedance
DE102013000966A1 (en) * 2013-01-22 2014-07-24 Zimmer Medizinsysteme Gmbh Method and apparatus for continuous non-invasive measurement of tissue temperatures at different tissue depths
US10299905B2 (en) * 2015-12-28 2019-05-28 Ethicon, Inc. Applicator instruments having off-axis surgical fastener delivery
WO2019071269A2 (en) 2017-10-06 2019-04-11 Powell Charles Lee System and method to treat obstructive sleep apnea
CN109730766A (en) * 2019-01-04 2019-05-10 成都博美医疗用品有限公司 One kind anti-burn neutral electrode and its working method
KR20220070347A (en) * 2019-03-14 2022-05-30 바이오데이타 뱅크, 인코포레이티드 Temperature sensor unit, and body core thermometer
CN113203917B (en) * 2021-04-25 2022-11-18 国网河南省电力公司平顶山供电公司 Method for pre-judging heating defect of diversion loop of reactive power compensation device
US20230190370A1 (en) * 2021-12-17 2023-06-22 Biosense Webster (Israel) Ltd. Irreversible Electroporation Return Electrode and System
EP4265211A1 (en) * 2022-04-21 2023-10-25 Erbe Elektromedizin GmbH Electrical surgery system and method for determining an electrode type of a neutral electrode

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541482B2 (en) * 1981-10-26 1985-01-10 Sherwood Services Ag Monitoring electrode connection in electrosurgery
US4416277A (en) * 1981-11-03 1983-11-22 Valleylab, Inc. Return electrode monitoring system for use during electrosurgical activation
DE3544443C2 (en) 1985-12-16 1994-02-17 Siemens Ag HF surgery device
US6258085B1 (en) * 1999-05-11 2001-07-10 Sherwood Services Ag Electrosurgical return electrode monitor
WO2005110263A2 (en) 2004-05-11 2005-11-24 Wisconsin Alumni Research Foundation Radiofrequency ablation with independently controllable ground pad conductors
DE102004025613B4 (en) * 2004-05-25 2008-08-07 Erbe Elektromedizin Gmbh Method and measuring device for determining the transition impedance between two partial electrodes of a divided neutral electrode
US20060079872A1 (en) 2004-10-08 2006-04-13 Eggleston Jeffrey L Devices for detecting heating under a patient return electrode
CA2541037A1 (en) * 2005-03-31 2006-09-30 Sherwood Services Ag Temperature regulating patient return electrode and return electrode monitoring system
US20070049914A1 (en) * 2005-09-01 2007-03-01 Sherwood Services Ag Return electrode pad with conductive element grid and method
US7637907B2 (en) 2006-09-19 2009-12-29 Covidien Ag System and method for return electrode monitoring
US8231614B2 (en) * 2007-05-11 2012-07-31 Tyco Healthcare Group Lp Temperature monitoring return electrode
US8100898B2 (en) * 2007-08-01 2012-01-24 Tyco Healthcare Group Lp System and method for return electrode monitoring

Also Published As

Publication number Publication date
US9289254B2 (en) 2016-03-22
JP5476390B2 (en) 2014-04-23
CN102202592B (en) 2014-10-22
CN102202592A (en) 2011-09-28
JP2012506744A (en) 2012-03-22
EP2367493A1 (en) 2011-09-28
PL2367493T3 (en) 2015-02-27
DE102009013917A1 (en) 2010-05-12
WO2010049145A1 (en) 2010-05-06
US20110202055A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
EP2367493B1 (en) Electrosurgical device having a temperature measurement device for determining a temperature and/or a temperature change at a neutral electrode
EP2043539B1 (en) Electrode device
DE60023985T2 (en) Surveillance device for electrosurgical neutral electrode
DE60026191T2 (en) Automatic activation of the bipolar output signal of an electrosurgical generator
EP1858428B1 (en) High-frequency surgical device
DE3838840C2 (en) High frequency coagulation device for surgical purposes
DE3516354C2 (en)
EP4164531B1 (en) Monitoring unit and high-frequency surgery system comprising such a monitoring unit
EP2155091B1 (en) Hf surgical testing device
DE19717411A1 (en) Monitoring of thermal loading of patient tissue in contact region of neutral electrode of HF treatment unit
DE102007051097A1 (en) HF surgical device and method for an HF surgical device
EP2537479A1 (en) Controlling a medical device depending on neutral electrode impedance
EP2992848A1 (en) Device for contact coagulation of biological tissue
DE602005005145T2 (en) Medical electrode assembly with possibility to monitor the treatment
DE4126607C2 (en) Arrangement for cutting biological tissue with high frequency current
WO2010037446A2 (en) Electrosurgical hf generator
DE102018114482A1 (en) Electrosurgical device
WO2013139443A1 (en) System and method for monitoring an endoscopic intervention
CH680702A5 (en)
EP2520241B1 (en) Device for tissue fusion or coagulation by means of tissue resistance-dependent voltage-controlled electric force
EP3030181B1 (en) Device for controlling a treatment process
DE112013001594B4 (en) Apparatus and method for measuring and controlling thermal effects in high frequency surgery
DE102016220157A1 (en) High-frequency generator
WO1998025532A1 (en) Ablation instrument for intracardiac treatments
DE102009017616A1 (en) Radio frequency ablation device for ablation of regions of tissue volume, has probe provided with coding that comprises dimension and/or condition of probe differing from dimension and/or condition of other probes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110527

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20131205

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/01 20060101ALI20140218BHEP

Ipc: A61B 18/16 20060101ALI20140218BHEP

Ipc: A61B 5/053 20060101ALI20140218BHEP

Ipc: A61B 18/12 20060101AFI20140218BHEP

INTG Intention to grant announced

Effective date: 20140314

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 684112

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140915

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502009009867

Country of ref document: DE

Effective date: 20141009

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20140827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141229

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141127

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141128

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141227

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

REG Reference to a national code

Ref country code: PL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502009009867

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141028

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

26N No opposition filed

Effective date: 20150528

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 684112

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20091028

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140827

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20221007

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231024

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231024

Year of fee payment: 15

Ref country code: FR

Payment date: 20231026

Year of fee payment: 15

Ref country code: DE

Payment date: 20231027

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20231004

Year of fee payment: 15